A Market-Based Mechanism for Global Vaccine Procurement Coalitions
Published Online:31 Oct 2025https://doi.org/10.1287/msom.2025.0036
References
- (2010) Nash equilibria in fisher market. Kontogiannis S, Koutsoupias E, Spirakis PG, eds. Proc. Internat. Sympos. Algorithmic Game Theory (Springer, Berlin, Heidelberg), 30–41.Google Scholar
- (2011) The price of fairness. Oper. Res. 59(1):17–31.Link, Google Scholar
- BioPharma Dive (2021) J&J foresees end to not-for-profit sales of coronavirus vaccine. Accessed October 1, 2025, https://www.biopharmadive.com/news/johnson-johnson-vaccine-not-for-profit-price/608477/.Google Scholar
- CEPI (2021) Joint COVAX statement on Supply Forecast for 2021 and early 2022. Accessed October 1, 2025, https://cepi.net/joint-covax-statement-supply-forecast-2021-and-early-2022.Google Scholar
- (2021) Centers for disease control and prevention as a strategic agent in the pediatric vaccine market: An analytical approach. Manufacturing Service Oper. Management 23(6):1398–1412.Link, Google Scholar
- (2016) Contracting for on-time delivery in the US influenza vaccine supply chain. Manufacturing Service Oper. Management 18(3):332–346.Link, Google Scholar
- (2009) Cournot competition under yield uncertainty: The case of the US influenza vaccine market. Manufacturing Service Oper. Management 11(4):563–576.Link, Google Scholar
- (2008) Market equilibrium via a primal–Dual algorithm for a convex program. J. ACM 55(5):1–18.Crossref, Google Scholar
- (2022) Reporting and data sharing level for covid-19 vaccine trials: A cross-sectional study. EBioMedicine 78:103962.Crossref, Google Scholar
- Duke Global Health Innovation Center (2022) The murky manufacturing landscape. The launch and scale speedometer. Accessed October 1, 2025, https://launchandscalefaster.org/covid-19/vaccinemanufacturing.Google Scholar
- Duke Global Health Innovation Center (2023) COVID-19 vaccine data. The launch and scale speedometer. Accessed October 1, 2025, https://launchandscalefaster.org/node/64.Google Scholar
- (1959) Consensus of subjective probabilities: The pari-mutuel method. Ann. Math. Statist. 30(1):165–168.Crossref, Google Scholar
- Gavi (2022a) COVAX: Key learnings for future pandemic preparedness and response. Accessed October 1, 2025, https://www.gavi.org/news-resources/knowledge-products/covax-key-learnings-future-pandemic-preparedness-and-response.Google Scholar
- Gavi (2022b) Germany to co-host 2022 Gavi COVAX AMC Summit, pledges additional funding for COVID-19 vaccination in lower-income countries. Accessed October 1, 2025, https://www.gavi.org/news/media-room/germany-co-host-2022-gavi-covax-amc-summit-pledges-additional-funding-covid-19.Google Scholar
- (2011) A perfect price discrimination market model with production, and a rational convex program for it. Math. Oper. Res. 36(4):762–782.Link, Google Scholar
- (2022) Costs and predicted financing gap to deliver COVID-19 vaccines in 133 low- and middle-income countries. Accessed October 1, 2025, https://www.unicef.org/media/114216/file/Costs-and-Predicted-Financing-Gap-to-Deliver-COVID-19-Vaccines-in-133-Low-and-Middle-Income-Countries.pdf.Google Scholar
- Guardian (2021) Revealed: Big shortfall in COVAX COVID vaccine-sharing scheme. Accessed October 1, 2025, https://www.theguardian.com/world/2021/apr/22/revealed-big-shortfall-in-covax-covid-vaccine-sharing-scheme.Google Scholar
- (2022) National responsibility for ecological breakdown: A fair-shares assessment of resource use, 1970–2017. Lancet Planetary Health 6(4):e342–e349.Crossref, Google Scholar
- (2024) Estimating the impact of regulation on business. Regulatory Rev. (February 28), https://www.theregreview.org/2024/02/28/hoguet-estimating-the-impact-of-regulation-on-business/.Google Scholar
- (2023) Partial or full doses first? Vaccine allocation under limited supply. Working paper, University of Toronto, Toronto.Google Scholar
- (2021) Overview of export restrictions on covid-19 vaccines and their components. ASIL Insights 25(10).Google Scholar
- Institute for Health Metrics and Evaluation (2022) COVID-19 vaccine efficacy summary. Accessed October 1, 2025, https://www.healthdata.org/research-analysis/diseases-injuries/covid/covid-19-vaccine-efficacy-summary.Google Scholar
- (2025) Stochastic online fisher markets: Static pricing limits and adaptive enhancements. Oper. Res. 73(2):798–818.Link, Google Scholar
- (1979) The Nash social welfare function. Econometrica 47(2):423–435.Crossref, Google Scholar
- (1999) Price discrimination and bargaining power in the us vaccine market: Implications for childhood immunization policy. Quart. Rev. Econom. Finance 39(2):249–265.Crossref, Google Scholar
- (2024) How manufacturing won or lost the covid-19 vaccine race. Vaccine 42(5):1004–1012.Crossref, Google Scholar
- (2022) COVID-19 vaccine wastage in the midst of vaccine inequity: Causes, types and practical steps. BMJ Global Health 7(4):e009010.Crossref, Google Scholar
- (2015) Vaccine prioritization for effective pandemic response. Interfaces 45(5):425–443.Link, Google Scholar
- (2022) Managing two-dose covid-19 vaccine rollouts with limited supply: Operations strategies for distributing time-sensitive resources. Production Oper. Management 31(12):4424–4442.Crossref, Google Scholar
- (2013) A game-theoretic model of international influenza vaccination coordination. Management Sci. 59(7):1650–1670.Link, Google Scholar
- (2021) Pricing the covid-19 vaccine: A mathematical approach. Omega 103:102451.Crossref, Google Scholar
- Our World in Data (2024) Population by income classification, world. Accessed October 1, 2025, https://ourworldindata.org/grapher/population-by-income-classification.Google Scholar
- Oxfam (2021) Vaccine monopolies make cost of vaccinating the world against COVID at least 5 times more expensive than it could be. Accessed October 1, 2025, https://www.oxfam.org.uk/mc/rekjvi/.Google Scholar
- (2023) A critical analysis of covax alliance and corresponding global health governance and policy issues: A scoping review. BMJ Global Health 8(10):1–10.Crossref, Google Scholar
- (2022) How relevant is the basic reproductive number computed during the coronavirus disease 2019 (covid-19) pandemic, especially during lockdowns? Infection Control Hospital Epidemiology 43(1):125–127.Crossref, Google Scholar
- (2014) The weighted set covering game: A vaccine pricing model for pediatric immunization. INFORMS J. Comput. 26(1):183–198.Link, Google Scholar
- (2021) Tracking global COVID-19 vaccine equity: An update. Accessed October 1, 2025, https://www.kff.org/covid-19/tracking-global-covid-19-vaccine-equity-an-update/.Google Scholar
- (2022) Efficacy of COVID-19 vaccines by race and ethnicity. Public Health 208:14–17.Crossref, Google Scholar
- (2023) Incentives and defaults can increase COVID-19 vaccine intentions and test demand. Management Sci. 69(2):1037–1049.Link, Google Scholar
- (2020) Business, energy and industrial strategy: International Vaccines Procurement Initiative (COVAX): UK participation. Accessed October 1, 2025, https://hansard.parliament.uk/commons/2020-10-14/debates/20101460000007/InternationalVaccinesProcurementInitiative(COVAX)UKParticipation.Google Scholar
- (2023) Research from low-income and middle-income countries will benefit global health and the physiotherapy profession, but it requires support. Physical Therapy 103(9):1–4.Crossref, Google Scholar
- (2009) Selfish drug allocation for containing an international influenza pandemic at the onset. Oper. Res. 57(6):1320–1332.Link, Google Scholar
- (2013) Multiregional dynamic vaccine allocation during an influenza epidemic. Service Sci. 5(3):197–215.Link, Google Scholar
- The Associated Press (2021) Timeline of virus vaccine deals reveals EU’s lag behind UK. Accessed October 1, 2025, https://apnews.com/article/europe-europe-coronavirus-pandemic-4903fca73b77f2ea65ca9d3e6e0e7a53.Google Scholar
- The New York Times (2021) AstraZeneca says it will start profiting from its vaccine. Accessed October 1, 2025, https://www.nytimes.com/2021/11/12/business/astrazeneca-vaccine-profit.html.Google Scholar
- The Telegraph (2021) Surplus of COVID vaccine doses will stand at 1.2bn in wealthy countries by the end of this year. Accessed October 1, 2025, https://www.telegraph.co.uk/global-health/science-and-disease/surplus-covid-vaccine-doses-will-stand-12bn-wealthy-countries/.Google Scholar
- The World Bank (2021) Supporting vaccine rollout in developing countries. Accessed October 1, 2025, https://blogs.worldbank.org/en/health/supporting-vaccine-rollout-developing-countries.Google Scholar
- UNICEF (2022) COVID-19 vaccine market dashboard. Accessed October 1, 2025, https://www.unicef.org/supply/covid-19-vaccine-market-dashboard.Google Scholar
- UNICEF (2025) Vaccines. Accessed October 1, 2025, https://www.unicef.org/supply/vaccines.Google Scholar
- (2020) Core allocations for cooperation problems in vaccination. Production Oper. Management 29(7):1720–1737.Crossref, Google Scholar
- World Health Organization (2020a) COVAX facility explainer: Participation arrangements for self-financing economies. Accessed October 1, 2025, https://www.who.int/publications/m/item/covax-facility-explainer.Google Scholar
- World Health Organization (2020b) WHO concept for fair access and equitable allocation of COVID-19 health products. Accessed October 1, 2025, https://www.who.int/docs/default-source/coronaviruse/who-covid19-vaccine-allocation-final-working-version-9sept.pdf.Google Scholar
- World Health Organization (2021) WHO, UN set out steps to meet world COVID vaccination targets. Accessed October 1, 2025, https://www.who.int/news/item/07-10-2021-who-un-set-out-steps-to-meet-world-covid-vaccination-targets.Google Scholar
- (2005) Optimization of influenza vaccine selection. Oper. Res. 53(3):456–476.Link, Google Scholar
- (2023) Fisher markets with social influence. Proc. AAAI Conf. Artificial Intelligence 37:5900–5909.Google Scholar

